Syndax Pharmaceuticals Inc (SNDX) › Shareholders' EquitySyndax Pharmaceuticals Inc (SNDX) — Shareholders' EquityAnnual figures by period end, from SEC filings.2013-12-31: -$128.47M2014-12-31: -$152.57M2015-12-31: -$252.41M2016-12-31: $84.14M2017-12-31: $104.32M2018-12-31: $53.05M2019-12-31: $31.60M2020-12-31: $252.19M2021-12-31: $408.37M2022-12-31: $467.45M2023-12-31: $554.20M2024-12-31: $288.12M2025-12-31: $64.63M$64.63M2013-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$64.63M-77.6%2026-02-26Balance as of period end2024-12-31$288.12M-48.0%2026-02-26Balance as of period end2023-12-31$554.20M+18.6%2026-02-26Balance as of period end2022-12-31$467.45M+14.5%2026-02-26Balance as of period end2021-12-31$408.37M+61.9%2025-03-03Balance as of period end2020-12-31$252.19M+698.1%2024-02-27Balance as of period end2019-12-31$31.60M-40.4%2023-02-28Balance as of period end2018-12-31$53.05M-49.1%2022-03-01Balance as of period end2017-12-31$104.32M+24.0%2021-03-12Balance as of period end2016-12-31$84.14M—2020-03-05Balance as of period end2015-12-31-$252.41M—2019-03-07Balance as of period end2014-12-31-$152.57M—2018-03-08Balance as of period end2013-12-31-$128.47M—2017-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)